tiprankstipranks
Diagnos Inc Grants Stock Options to New Director
Company Announcements

Diagnos Inc Grants Stock Options to New Director

Diagnos Inc (TSE:ADK) has released an update.

Don't Miss our Black Friday Offers:

Diagnos Inc., a Canadian company specializing in early detection of health issues with AI technology, has awarded 250,000 stock options to new board director Mr. Michael Braeuel, with a vesting period of 50% per year and an exercise price set at $0.28 per share. These options, granted on March 4, 2024, are exercisable until March 4, 2029, marking a significant corporate governance event for investors.

For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskDiagnos Inc. Grants Stock Options to Leadership
TipRanks Canadian Auto-Generated NewsdeskDIAGNOS Inc. Shareholders Approve Key Proposals
TipRanks Canadian Auto-Generated NewsdeskDiagnos Insider Ownership Shifts Post-Share Placement
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App